, because i think merck's ready to play catchup. i just think its time is coming. how can i say that with all these recent negatives? first of all, some of these things are overblown. like whether merck's diabetes 2 drug really causes pancreas problems. this issue has been kicked around for years. merck has done some really good studies and had a pan cee tights on the label since 2009. the important thing to recognize is that the fda hasn't reached any new conclusions. they are just doing a study. a super fast growing drug doctors are very comfortable with because it does a terrific job of controlling blood sugar in patients with type 2 diabetes. and given that the drug's sales were up 25% last year, i think this drug is the reason to buy merck, not a reason to sell it despite those recent, hideous headlines. let's forget about the headline risk for a second. why don't we look at the fundamentals. right now merck has the least exposure to drugs losing patent protection of any of the big pharma companies. merck is a terrific animal h

plus, a spec shipping play and jim's prognosis for merck. it's all ahead on the eighth anniversary edition of "mad money." okay, it is time for the buck stops here. the final word from the fx market. todd, kick it off for us. >> you have to go long the irish on st. paddy's day. no, just kidding. i'm long euro right now. i'm long the australian dollar. i think those employment numbers were a blowout. i think we're in this dollar weakening phase gun. >> not wearing the green for nothing, todd. b.k.? >> again, love the euro trade. i think there's a catalyst coming in this week. not only, like andy said, you could get a surprise out of italy, but say they don't form a government. a government, i again think that makes the euro closer to becoming the german deutsche bank. >> and i like to hopefully get you into the position or out on wednesday or thursday when you get better than expected pmi numbers. >> amelia. >> i'm sure it's sterling and me gusta like todd. happy st. paddy's day. >> indeed. that's it for "money in motion." thank you so much f

merck is up 3.3%.can people, stuart. we're looking at the drug vytorin, and now they've gotten the word that they continue the trial with this drug. so, the panel, an independent monitoring board says they'll continue with the huge trial assessing the safety and effectiveness. a couple of things, number one, they're calling the study improving. because nobody found there are any safety concerns that have arisen with vytorin. some analysts hope the independent monitoring group says hey, it's great right now. but instead they will continue and just the fact that they're continuing and moving forward with it is good news. >> just the point that they're continuing with the-- and that's a positive, obviously, for the stock, it's up 3%, and when you get a 3% move in stock the size of merck, nicole, thanks indeed. we're talking about the new phone from samsung, here is todd hazelton from techno buffalo, he was in the last hour, talking about whether the new samsung phone is is an iphone killer. >> so, everybo

. >> that is now the most-held stock -- >> i see merck going higher. i see more comfortable when the market is being led by companies like mcdonald's. that makes me feel good. because that means people aren't speculating. >> mcdonald's seems like a good stock. >> i haven't seen a list of com

we'll be right back. -- merck.y: let's take a look at the dow 30 components for you on the upside, we see merck and united health, boeing, forget about the problems for dreamliner that stock keeps on going. on the down side, caterpillar, walt disney. let's go to the floor of the new york stock exchange where nicole petallides is standing by. nicole: doreen mogavero has been here a long time even though she's very young and can give us some perspective on the market action we are seeing. another day, another record high, today is different because now we are seeing the weakness setting in. what do you think? >> there's been a lot of talk today about obviously things sort of stalling here and people are tired. s&p trading at some point 8% above its 200-day moving average which is generally a signal that things -- some people say 10%. some people say 8% but whatever. but it is in a zone where people are starting to get nervous. a lot of talk about overbought conditions. so i think in general people are taking a little

merck, bristol. go across the entire area. lily. they all seem cheap.hat's an area i've been adding to. that along with energy. i'm a little puzzled by the financials right now. >> joe, got to figure we're going to get the record. it's a matter of time the s&p is going to get that closing high. where are we going to go? earnings season is in front of us now. that's going to be the tale. >> we're going to continue to move higher unless we get some storm of evidence to suggest otherwise. i just don't see it. you have to look at overall sentiment here. there is negativity that continues to prevail throughout the markets. look at the composition of today's rally, again, that tells you the story. 46 new highs. the majority of those are in consumer noncyclical which i think will work as we move forward. consumer staples. utilities working well today. so as pete talks about, yes, the financials aren't participating today, they will come around. they have participated throughout much of the year. but it's a rally that no one trusts and i think scott, ultimately

cholesterol, and that's helping merck and the dow.oeing, united health care, and walmart, other names help it along. the vix fear index back with up arrow. back to you. dagen: thank you. markets continuing to hit all time high, and high yield bonds, how pricey are the invosments? should you be worried if you own them? connell: first guess with $40 billion in management, high field, head of leveraged finance, here at black rock. good to see you. thhnks for coming in. the target had the advance to a record, and people are stuck or are in drsh i don't know if "stuck" is the right word, but make the case for risk today, if you can, for us. >> uh-huh. i think it's what types of risk do you want to own in this economic environment, and, you know, we've been dealing for the last five years of everybody trying how to you protect the money? the probabilityings of that deflation or recession outcome was real. central banks around the world and fiscal governments evolve policy derisking the downside. what you see now is people trying to say what

. >>> meantime, shares of merck jumping 3%.g maker got the green light to continue trial on cholesterol drug vitorin. is the signal more upside from the stock? steve grasso is joining us from the floor of the sye. stock is up 4% on the market. peeled a little off. how do you read it? >> enwhich ever you look at this, especially on a technical of a name, you see these stocks spike or you see them crater. you always want to take the profits when you see a stock spike like this. it's running it to major resistance from back from december 2012. so i think you would be extremely responsible to take the profit. it's the same way if a stock craters, you kind of want to leave it alone before you buy t it. it's a two-day rule. >> is this a name -- what other names do you like in the space? >> if you look at pfizer, advertiser is a much more reliable chart. i've owned pfizer forever. it's a small position. i've owned it forever. if you look at the charts and compare them it's a much more dependable chart on a technical basis. for me, i w

time to bring in axel merck. your thoughts? >> good morning.hen someone screams fire, you do not want to shut the accident. halting stocks, i do not think, is helpful at all. i think it is rather responsible. the question is what will happen. obviously, investors are taking action. connell: you just look at the big board here in the united states and the green at the beginning of the day has now turned red. european markets losing some steam. you talk about the italian banks and how it would not be a good idea to halt the trading. is there almost north south european divide where the rich and the north are epitomized by what we see in germany and some of the troubled companies in the european south that it is not just about cyprus? if so, how does that dynamic and financially? >> we had a credit bubble. if you build wealth based on a credit bubble, when the bust comes, something will hurt. a credit bust is not as painful. a credit bust can truly wipe you out. the way this goes forward is, obviously, these adjustments will have to be made. germa

so ge, at&t and merck are three great examples. ge, they are a great blue chip stock right now.ed product line. they are building light bull. s to jet engines and one of those companies that don't mind diving into their war chest. and spending money in the company. we really like that quality. >> but tony, when you talk about ge and at&t and merck, why haven't they done well why why haven't they participated? >> well, i'm not concerned if they haven't. if they haven't participated, that's fine. i'm looking at people who got beat up. so gm stopped paying dividend and now brought it back and maybe it'll take confidence for investors to get back in, but you know, i really think on a going forward basis, some of the stuff we're seeing with ge for example, are positive movements for those kind of stocks. >> and you picked stocks from dinosaurs of the dow. one which is down 78% since october 2007 high. >> you're talking about alcoa there, aren't you? >> yes. >> we look at alcoa and stock prices and oh, my gosh, you look at levels. let's look at aluminum demand in 2012. up 12%. expect

back in the 1990s, during the heyday of big pharma, the major drug companies like the mercks, pfizers, they were thought of as rock stars, growth stocks and they sold for as much as 30 to 40 times earnings. the biggest patents expired, the growth diminished or vanished entirely and big pharma became a nice defensive place to find stocks with high yields, fixed income alternatives. but the truth is, inventing new drugs can still be a fabulous growth business. maybe the best there is. just that these days the real innovation is happening at a different set of companies. that's why i've been saying the important biotechs of today represent the future of pharma. they are well on their way to being the next big pharma names. so far this week, i've recommended celgene, gilead and biogen idec, which you might have heard earlier today on "closing bell." today i've got one more biotech that fits the mold. this stock exemplifies the growth trajectories i'm talking about. i'm referring to regeneron pharmaceuticals. right now it's a $176 stock that's $12 off the 52-week high. it's got a market ca

i'd much rather own like i mentioned at the top of the show an amgen or abbott labs or merck.ing a 10, 12 valuation. >> i eel take the other side. i think it's a great name because of the stable growth. over the last five years. although you're going to pay a premium because it's a premium name because of the dividend and the number they're putting up you own general mills here. >> my problem right now is the fact that their margins are going down. i think it's priced to perfection. great stock, well managed. they're doing everything they can. but i think they have priced themselves perfectly. i would wait for a pull back. >> corn and wheat prices have come in though. if they stay in, i don't believe they will, and hopefully the guys are putting on some hedges that's their business. putting on the hedges for the inputs, wheat, corn, rice the rest of it. i think general mills is a good do here, but it's scary. >> sounds like we're split. interesting, again. cramer will have the ceo on tonight. finally ebay says it will overhaul fees for sellers in a bid to step up competition w

you come in, merck would be up 6 and then 3 and then 7 and then close for the weekend.n you do, didn't trade saturday. opened up 10 monday. yeah, check out that chart in '86, '87. gilead has a robust pipeline and game-changi game-changing hiv drug. gilead the stock has slow-growing names that we're familiar with phrma today, cheaper, even though it's a rapidly growing biotech. this stock may have room to run. i think it deserves to go much higher. chris in california. chris. >> caller: hey, jim. i've been watching mankind corporation stock for a while. they've had some great medical products in the past. and they're currently awaiting an fda approval for an insulin delivery system that would eliminate injections. any thoughts here? >> yeah, to serve mankind, it's a cookbook. no, i don't want you in mankind. i'm talking about the highest level kind of drugs here. i'm talking about bristol-myers and gilead gore growth. we don't need to go down the food chain to mankind. let's go to joe in florida. joe. >> caller: hey, jim. this is a big florida boo-yah to you. >> good to

merck gained 3% on the day while pfizer lost ground. >>> president obama's nominee to chair the securities and exchange commission says she'll be an investor advocate. mary jo white questioned by senators at her confirmation hearing this morning said that if confirmed the american public would be her client and that she would not back off if there was any evidence of wrongdoing at major institutions. >> assuming you found wrongdoing, i think you'd proceed quite vigorously against effectively anyone that you find evidence of wrongdoing on, but certainly financial institutions at the sec, which of course, doesn't have the criminal powers, those consequences are not taken into account before charging decisions are made so that the sec, there's no institution too big to charge. >> white is expected to get the okay for that sec job especially after republican senator tom coburn of oklahoma announced he would aggressively support her nomination. >>> there's not a lot of support for h & r block today after a software snag has delayed the returns for a lot of americans who have already filed their

bristol-myers squibb leading the way up almost 25% year to date, followed by eli lilly, pfizer, amgen and merck. >>> it is set to become one of the ten largest shareholders in goldman sachs. the move comes as goldman gives berkshire millions of shares in place of warrants dating back to the depths of the financial crisis and that's when buffett came to the rescue of the wall street firm by investing $5 billion. goldmaniay stock was closing at their 146. at that price berkshire would receive 9.5 million shares. netflix was the biggest gainer in the s&p 500 today after an analyst boosted the company's price target to $225. he says the company's streaming video business has the potential of drawing in more subscribers. netflix shares have doubled this year and they rose today to $190 and that's a gain of 5.5%. >> a historic hearing on the u.s. supreme court on whether same-sex couples would have time to rally. john harwood joins us from the supreme court in washington. what did the justices hear today? >> the two-day sense of argument on same-sex marriage. tonight it was about ate, ban gay maerj a

for more, let's bring in the president and chief investment officer of merck investments. great to speak with you. >> great to be with you. >> we saw a fairly big move in the euro today. i'm wondering what you think is going to unfold next week. >> well, you guys pointed out, bernanke's all that matters. there is somebody on the other side of that trade, the european central bank. the europeans have been mopping up liquidity. the americans, the brits, the japanese, all printing money like crazy. i disagree with the notion that they will always fix it and that's why the market is up. is market is up even if cyprus were to melt down. what people have realized is that cyprus is not contagious. we have treasury auctions in spain last week that went great. if people were pricing in the remote chance of contagion, we wore very different where we are today. clearly, this weekend can do many things. going to be many rocks in this road. but in europe, they're not printing this money. that's why these problems and, you don't want to have the euro in a separate bank account, but if y

. >> here we have merck announcing a vytorin. this is anti-cholesterol.mportant stock on the dow is a couple and with the costco reports. it's good, and 50% of cabella's is hunting. we know gun sales, david, are incredibly strong in this country, but i just keep coming back to the facts of the individual companies just don'ta ad up to the triple top. they don't add up to exhaustion. they print their numbers really, really early. we get up early and i was, like, wow, that's better than i thought. >> does a rising multiple give you any -- >> i hate multiple expansion. >> that's what we're getting that the point. i don't see a lot of numbers coming up at this point from the analysts from the second half of the year or guidance. >> i think people feel to raise guidance in the face of sequester. i keep coming back to mark zandi and saying maybe housing starts are better, autos and what are you smoking? what i'm smoking is a sell to hold sherwin-williams at credit suisse and value added since the stock was at 80 not that long ago, but i just keep finding out. t

if merck can do this and it does get axe proved and it is the next leap merck will be dramatically higherll or no? >> there's not much to say new today, right? carl icahn's in there. i did notice they signed up citi as another bank. when you think about blackstone signing, you know this, as well the biogroups signed up almost all of the banks out there which questions, at least the ability to raise the financing if you were not a counterbid which i think is highly unlikely. what do you think? >> i'm completely in agreement. there it is. >> that's what i like to hear. >> a "squawk on the street" agreement. i like that. >> worst over for young? >> you bet it is. they'll wait until 75 because they're stooges. i'm sorry. they're misinformed. >> we have to run and we'll get the last word from our guest host after this break.

raising, row after row fashioned -- fishermen houses are vented battered by debris we move through merck and ink after the poet set off to search the far north as well as the injury chains of the mind he lost his way in the verge from the forest it was a thriving seaport writing merchant ships gathered in the bay and in the town had smoke rose continuously from the salt kiln site thought i'd never intended to come to a place like this. we look for lodging but were refused by everyone. with you right on this page of destruction? an aftershock rattles the car windows. the road is 2 feet higher but not enough. high tide water splashes against the tires. this part moved east 17 feet and downward to free. now water enters and reenters every boat and house and living room. when the water drains a single line of cars and trucks go over bridge the sea wall to protect the town is completely submerged, rubbish, a 200-foot high wall lions' one point* and smashed cars are stacked three high. a paper factory in ruined the sawdust piles blowing, a small river obstructed by a boat. then driving on the

we moved through merck and ink. in the spring of 1689 one wandering put set off to search far north as well as the inner regions, lost his way and emerge from the forest. even then it was a thriving seaport not much to his liking. hundreds of merchant ships were gathered in the bay. and smoke rose continuously, i thought to myself i never intended to come to a place like this. we refused by everyone. where was bosh0 right now on this page of destruction? an aftershock rattled the car windows, the latest two feet hired is not enough. at high tide water splashes against the tires. this area moved southeast 17 feet. and down two feet. all over the port, water enters and reenters every wrecked boat, house and living room. when the tide recedes, water drains from the road as well from a boat discovers a single line of cars and trucks bumps over of ridge. the sea wall to protect the town was submerged, rubbish play 200 foot wall of it, lines one side of the road and on the other smashed cars stacked three i. a paper facto

we raided 74 businesses merck office, and arrested 500 people in those businesses here illegally, withd.es. so he ought to say, thank you, you're making openings for those here legally they need a job and, as you say, we do have an unemployment problem. so why would you want to give these jobs to people that violated the law, come in here illegally? let's save the jobs for u.s. citizens. >> neil: amazing, sheriff, feel better. get that shoulder become up to speed you. got a lot of weight on it here. good seeing you. joe arpaio, good. >> i want you to look at something. these folks shouting in the streets? they just learned they can't get money from their banks because their government is closing them. now, i know what you're thinking. that is going to create a bank run there, right? what if i told you it's already igniting fears of a bank run here. . all stations come over to mission a for a final go. this is for real this time. step seven point two one two. rify and lock. command is locked. five seconds. three, two, one. standing by for capture. the most innovative software on the pla

i have no relationship with the viagra manufacturers, of merck, but i did do a campaign for merck years trying to raise awareness that erectile dysfunction is a sign of heart disease. so it is important to remember, as people are expecting to stay sexually active longer and start having dysfunction, medical problems and hormonal issues and vascular diseases are the number one problem affecting sexual function. so, please, people, if you have a problem with performance, before you reach for a pill, before you think it is a psychological problem, talk to your physician. it is really an important message here. >> okay. i want to talk about the women here, dr. drew. because look at the wall street journal, below the fold is the headline, oh, my, that dirty book sold 70 million copies. i'm talking about 50 shades of grey, 70 million copies. is this the women's viagra? it seems to me that for women, it is much different. it is like psychological versus the physical, yes? >> that's -- remember, the viagra only affects erectile function, doesn't affect libido. women are saying this -- 50 shades

merck leading the dow on the other side of this. nicole: that is right. an independent board looking at it, they will continue the trials they found so far continuing into 2014. the dow today hit new record intraday high. david: i wonder what makes you feel like when rumors of her demise sends your stock going up. that is what happened to jcpenny's because the ceo might be leaving. nicole: and then a spokesperson for the company came out and flat out denied that and called it false but the stock was jumping big-time. it would be better if we said something like jcpenney sales are so great. liz: we have dick's sporting goods, but it has cut the radio show. nicole: they are not really a takeover target so golde goldma. they had too much cold weather gear, and it was a little bit more mild and goldman sachs says once the weather issue passes, i think they will recover same-store sales, so positive on dick's. david: all the banking stocks had a rough day. morgan stanley, others down. nicole: the riskier plays per out of favor. liz: let's just listen to that o

. >>> merck moving up, an independence monitoring board has allowed it to continue its trial on the safety and effectiveness of the blockbuster vytorin. and there you see the stock. pfizer moving a bit lower, the fda said the zmax can cause a heart. >>> dialing up the heat, at&t announcing consumer and corporate presales of the new blackberry z-10 phone opening today. it comes ahead of samsung's much anticipated release of the latest galaxy phone. blackberry shares up 25% so far this year -- well, actually about 20%, according to that chart at 14.30, a bit lower right now by about 60 cents today. jon fortt is at an at&t store out in the valley, silicon valley, that is. jon? >> reporter: yeah, here in palo alto in high hopes both that at&t and at blackberry over the z-10 launch. blackberry's been down quite a bit, but the z-10, which we attended the launch back in january, it goes on sale on the 22nd, about $200 with a service agreement, about you same price as the iphone 5. at&t coming forward with it first, but t-mobile and vising also expected to sell it. sprint looking to sell other bla

i have a roth ira and it contains pepsico, pep, merck, mrt, oracle and orcl and emerson electric, emr energy, su. and i just want to be diversified, but i wanted your opinion if i should dump sun corps energy and switch to the international? >> no, keep the sun corps energy and once a favorite of gary kaminsky who i will miss a great deal. oracle bought that, and i think we have a good number last week and pepsico is a beverage company and snacks and emerson industrial and we have oil, we've got industrial, snacks and soft drink, carbonated and we've got water, too, and we have tech and we have drug. i don't know. that seems darn good to me. i wouldn't make any changes. >> let's go to john in wyoming. john? >> all right. i have center point energy, which is cnt. bristol-myers squibb, which is bmy, ge, ge in waste management and it's wm and kellogg. am i diversified? >> john came to play clearly from larmamie? it will close because of the sequester they're worried about. we have cereal, okay? we've got -- consumer packaged goods and bristol-myers, my charitable trust owns and center po

throughout merck that they shut off.oing wasn't the time or place for the 15-year-old. main thanks to i told him not getting a signal, that's grady stuff. larry cut low and we will be back tomorrow morning

the marketplace starved astrazeneca, glaxo, merck and pfizer. >> we are going to veto it. this is like the mets without having dickey, okay? we get the picture right, clear on that one? don't buy. let's go to tyler in virginia. tyler. >> caller: boo-yah, dr. cramer. >> boo-yah. >> caller: i like your opinion on travel centers of america. i got in it two months ago and it's up 40%. ring the register or hold on? >> i've been looking at this company trying to figure out what they are going to do with natural gas. the answer is, i've got to hold this, do homework and give you a much better view on it. it seems too exciting to me. let's go to edie in washington, d.c. edie. >> caller: this is edie. this is a reit question. what is your opinion of two harbors concerning the issuance of 50 million common shares, shares of spy their spin-off and lowering their dividend? >> look, we don't want to see all that happen. remember, these are companies that do variable dividends, okay? whether it be anly or agnc. these are companies that do that and reinvest that money. don't worry about

merck, pfizer and sciences are among the drug makers are among those with the hiv drugs. gilead down just a penny. >> such a fantastic story, ty. >>> we have been flirting with the unchanged level. we are down only about 4.5 point and s&p is positive. not by much, just a half point but heck, the bulls will take it and nasdaq composite is up half point, ty. so mark set improving today. >> anyone who thought the big spending cuts were going to absolutely eek out the market, they would be wrong for at least today. thank you very much. thank you for watching. that does it for "power lunch." >> "street signs" begins now. ty and i will see you tomorrow. have a great afternoon. >> warren buffett, china and the markets trying to make a come back, oh, my. that kind of a day here on "street signs." we will tell what you the chinese government did that has some investors spooked. >>> warren buffett says some stocks are still a bargain and he is a buyer of a buffet of names that he likes, ahead. >>> why some mortgages will look like sub prime mortgages and one trade in commodities yo

template to find the stocks of the next big drug companies, the ones that deserve to trade the way merck and eli lilly and pfizer did in the 1990s. and that is why all week we've been highlighting the larger biotech plays, companies with terrific prospects like celgene and gilead. right now, they're the ones doing the innovating. and tonight i've got a new one for you, and that stock is biogen idec, biib. it's a major biotech that hit a new 52-week high today and $183 as the stock soared $5.60, up more than 3% after the fda approved their new multiple sclerosis drug. don't be scared away. it's had a rally since i recommended it last january at $117, when everybody i know thought it was already too high, and it's given you a 56% gain. but please, remember the analogy here. back in the '90s when the stocks were on fire, they would run and run some more and run some more year after year. biogen today is no different. even at the 52-week high, the stock is far from expensive on the earnings. sells for 19 times next year's earnings with an 18.3% long-term growth rate. that's kind of nuts, isn

merck up more than 3% on news about its cholesterol drug.aising the commodity sector to overweight today. gold up 1370, settling at 1591. crude-oil up $0.48 per barrel settling in 9254. in the bond market the ten year treasury slipping. overall a slight pullback in the market today. the wilshire 5,000 moves in 50 billion. the beginning of this month the market is up 425 billion. particularly with the savants and bruce. corrections slauson large percentage retracement. those careers and savant's. we will see. a former ceo of aig more than doubling down in his lawsuit against the federal government. the class action lawsuit that he is leading seeking $65 billion from the government first unconstitutional. unnecessary. a treasury official tells fox business, they still believe the lawsuit is without merit, and we will see. we will see what happens when president obama tomorrow meets with house republicans. that will be their first meeting since june of 2011 when there were also talking budgets. joining is now to talk about tomorrows meeting and

that one is moving higher by a third of a percent, and then that's got drug makers like merck, pfizertechnology stocks are underperforming the market though a bit. the spider select xlk etf, while it's moving higher, it's just by a fraction. now, part of the reason may be apple. apple is part of the xlk. shares are reversing, actually, higher by about five points, so we're looking at a real move to the upside compared to what we had seen earlier today. credit agricole downgraded the stock from a five to an outperform, but the people who are bullish on this one are in today. now, ford, let's look at that one. ford is moving up about a half a point. this is the spa day picture after the auto giant said deliveries rose 40% in january and february. that's better than expected. let's also look at valero energy, and you can see that one is moving down just about a dollar, fifth day in a row as gasoline prices are falling. so with the dow hitting yet another record high and the s&p 500 now within spitting distance of all-time highs, our traders spread across a whole bunch of trading floors a

i'm not sure, justin, you tell me, america and coca-cola didn't see up side move -- merck.ome up in last minutes of trade? that was it. back to you, david. david: a red-letter day in the market no doubt. today's history-making run-up in the stock market has the backdrop of a weak economy but bulls say the housing market could provide economic support for a continuing bull market. if anyone knows housing he is our next guest. he is legend in the housing industry. eli broad is founder of kb hopes which helped turn generation of baby boomers into homeowners. he helped reshape and rebuild los angeles into one of the world's leading cultural center. he is founder of the broad foundation and the author of most recently of the, the art of being unreasonable. welcome to fox business, eli broad. wonderful to see you again. thank you for coming in. >> good to be with you. david: unreasonable is part of your book. the art of being unreasonable. i wonder if you think the market is being unreasonable right now? we have a very slow growth rate of under 2%. we have very high unemployment

kevin nolte ended his career at merck with this photo.always bear your chest in the company newsroom. >> i'm here to tell you i'm quitting. >> or simply march out with a bandic like joey defrancesco. dab raw ferric, cnn, new york. >> that's one way to go, i suppose. let's get caught up on some of the other stories we're following. >> lawyers for the theater shooter filed court documents today. he's accused of killing eight people and wonunding 58. >> bruce davis, a former follower of manson is not getting parole. they said the 70-year-old still poses a threat to society. he's serving two life sentences for killing two men back in 1969. >> and a dog owner believes her prized pooch was poisoned at the famous westminster dog show in new york city. he died last month, four days after competing in that show, anderson. >> so bizarre. appreciate that. thanks very much. we got word that president obama has signed the sequestration order that goes into effect at the end of the evening tonight, i think around midnight time. >>> coming up inside the

kevin nolte ended his career at merck with this photo.don't care, bear your chest in the company lunchroom. >> i'm here to tell you i'm quitting. >> or simply march out with a band, like joey defrancesco. deborah feyerick, cnn, new york. >> that's one way to go, i suppose. let's get caught up on some of the other stories we're following. randi kaye is here with the 360 bulletin. >> lawyers for the theater shooter filed court documents today. he may plead not guilty by reason of insanity. he's accused of killing 12 people and wounding 58. >> bruce davis, a former follower of manson is not getting parole. jerry brown has revrsed a parole board decision, saying he still poses a threat to society. he's serving two life sentences for killing two men back in 1969. >> and a dog owner believes her prized pooch was poisoned at the famous westminster dog show in new york city. a sam " -- samoyed named cruise died four days after competing in that show. anderson. >> so bizarre. appreciate that. thanks very much. we got word that president obama sign